Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?

J Diet Suppl. 2018 Jan 2;15(1):124-128. doi: 10.1080/19390211.2017.1326432. Epub 2017 May 30.

Abstract

Use of omega-3 in psychiatric practice is on the rise. It has been used in diverse indications, notably mood disorders, schizophrenia, dementia, borderline personality, and neurodevelopmental disorders, with varying levels of evidence base. Here, the author sheds some light on the therapeutic potential of omega-3 as an appealing addition to psychopharmacological armamentarium.

Keywords: omega-3; psychiatric use.

Publication types

  • Review

MeSH terms

  • Borderline Personality Disorder / drug therapy
  • Dementia / drug therapy
  • Evidence-Based Medicine
  • Fatty Acids, Omega-3 / therapeutic use*
  • Humans
  • Mental Disorders / drug therapy*
  • Mood Disorders / drug therapy
  • Neurodevelopmental Disorders / drug therapy
  • Psychotropic Drugs / therapeutic use*
  • Schizophrenia / drug therapy

Substances

  • Fatty Acids, Omega-3
  • Psychotropic Drugs